1. SEER Cancer Statistics Factsheets: Female Breast Cancer. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/statfacts/html/breast.html (5 November 2015, date last accessed).
2. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Ann Oncol,2014
3. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Breast Cancer. Version 3.2015. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf (5 November 2015, date last accessed).
4. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study;Cortes;Lancet,2011
5. Halaven 0.44 mg/ml solution for injection [summary of product characteristics]. Hertfordshire, UK: Eisai Europe Limited.